Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells

Chronic myeloid leukemia stem cells (CML LSCs) are a rare and quiescent population that are resistant to tyrosine kinase inhibitors (TKI). When TKI therapy is discontinued in CML patients in deep, sustained and apparently stable molecular remission, these cells in approximately half of the cases res...

Descripción completa

Detalles Bibliográficos
Autores principales: Houshmand, Mohammad, Kazemi, Alireza, Anjam Najmedini, Ali, Ali, Muhammad Shahzad, Gaidano, Valentina, Cignetti, Alessandro, Fava, Carmen, Cilloni, Daniela, Saglio, Giuseppe, Circosta, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708315/
https://www.ncbi.nlm.nih.gov/pubmed/34945101
http://dx.doi.org/10.3390/jcm10245805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708315/
https://www.ncbi.nlm.nih.gov/pubmed/34945101
http://dx.doi.org/10.3390/jcm10245805

Ejemplares similares